Maintenance of Acromegaly Control in Patients Switching From Injectable Somatostatin Receptor Ligands to Oral Octreotide

PURPOSE: The phase 3 CHIASMA OPTIMAL trial (NCT03252353) evaluated efficacy and safety of oral octreotide capsules (OOCs) in patients with acromegaly who previously demonstrated biochemical control while receiving injectable somatostatin receptor ligands (SRLs). METHODS: In this double-blind study,...

Descripción completa

Detalles Bibliográficos
Autores principales: Samson, Susan L, Nachtigall, Lisa B, Fleseriu, Maria, Gordon, Murray B, Bolanowski, Marek, Labadzhyan, Artak, Ur, Ehud, Molitch, Mark, Ludlam, William H, Patou, Gary, Haviv, Asi, Biermasz, Nienke, Giustina, Andrea, Trainer, Peter J, Strasburger, Christian J, Kennedy, Laurence, Melmed, Shlomo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Online Only Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470473/
https://www.ncbi.nlm.nih.gov/pubmed/32882036
http://dx.doi.org/10.1210/clinem/dgaa526

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470473/
https://www.ncbi.nlm.nih.gov/pubmed/32882036
http://dx.doi.org/10.1210/clinem/dgaa526

Ejemplares similares